We have investigated the SAR of a series of pyrimidinone-containing Cdc7 kinase inhibitors. A wide range of amine substitutions give potent compounds with activities (K-i) less than 1 nM. Kinase selectivity is reasonable and cytotoxicity corresponds to inhibition of MCM2 phosphorylation. (c) 2012 Elsevier Ltd. All rights reserved.
作者:Keith W. Woods、Chunqiu Lai、Julie M. Miyashiro、Yunsong Tong、Alan S. Florjancic、Edward K. Han、Niru Soni、Yan Shi、Loren Lasko、Joel D. Leverson、Eric F. Johnson、Alexander R. Shoemaker、Thomas D. Penning
DOI:10.1016/j.bmcl.2012.01.041
日期:2012.3
We have investigated the SAR of a series of pyrimidinone-containing Cdc7 kinase inhibitors. A wide range of amine substitutions give potent compounds with activities (K-i) less than 1 nM. Kinase selectivity is reasonable and cytotoxicity corresponds to inhibition of MCM2 phosphorylation. (c) 2012 Elsevier Ltd. All rights reserved.